These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20226889)

  • 21. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines.
    Nimmannitya S; Hutamai S; Kalayanarooj S; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):689-93. PubMed ID: 9139377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.
    Kumar R; Tripathi P; Rizvi A
    N Engl J Med; 2009 Apr; 360(14):1465-6. PubMed ID: 19339732
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K; Rani R; Vrati S
    Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age.
    Kaltenböck A; Dubischar-Kastner K; Schuller E; Datla M; Klade CS; Kishore TS
    Vaccine; 2010 Jan; 28(3):834-9. PubMed ID: 19857447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children.
    Gnanashanmugam D; Troy SB; Musingwini G; Huang C; Halpern MS; Stranix-Chibanda L; Shetty AK; Kouiavskaia D; Nathoo K; Chumakov K; Maldonado YA
    Pediatr Infect Dis J; 2012 Feb; 31(2):176-80. PubMed ID: 22146742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological response to trivalent inactive influenza vaccine in HIV-infected children with different immunologic status.
    Kosalaraksa P; Srirompotong U; Newman RW; Lumbiganon P; Wood JM
    Vaccine; 2011 Apr; 29(16):3055-60. PubMed ID: 21349365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
    Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
    Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51.
    Dubischar-Kastner K; Eder S; Buerger V; Gartner-Woelfl G; Kaltenboeck A; Schuller E; Tauber E; Klade C
    Vaccine; 2010 Jul; 28(32):5197-202. PubMed ID: 20541581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
    Capeding MR; Alberto ER; Bouckenooghe A; Laot TM; Chansinghakul D; Monfredo C; Machabert T; Feroldi E
    J Infect Dis; 2018 Jan; 217(4):567-571. PubMed ID: 29325161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
    Kosalaraksa P; Watanaveeradej V; Pancharoen C; Capeding MR; Feroldi E; Bouckenooghe A
    Pediatr Infect Dis J; 2017 Apr; 36(4):e108-e113. PubMed ID: 28030526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region.
    Dubischar KL; Kadlecek V; Sablan JB; Borja-Tabora CF; Gatchalian S; Eder-Lingelbach S; Kiermayr S; Spruth M; Westritschnig K
    Pediatr Infect Dis J; 2017 Sep; 36(9):898-904. PubMed ID: 28430748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis.
    Jelinek T
    Expert Rev Vaccines; 2013 Aug; 12(8):859-69. PubMed ID: 23984958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Sep; 45(5):637-42. PubMed ID: 17683001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children.
    Feroldi E; Capeding MR; Boaz M; Gailhardou S; Meric C; Bouckenooghe A
    Hum Vaccin Immunother; 2013 Apr; 9(4):889-97. PubMed ID: 23442823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
    Sricharoenchai S; Lapphra K; Chuenkitmongkol S; Phongsamart W; Bouckenooghe A; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
    Pediatr Infect Dis J; 2017 Feb; 36(2):e45-e47. PubMed ID: 27846060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
    Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
    J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART.
    Belaunzarán-Zamudio PF; García-León ML; Wong-Chew RM; Villasís-Keever A; Cuellar-Rodríguez J; Mosqueda-Gómez JL; Muñoz-Trejo T; Escobedo K; Santos JI; Ruiz-Palacios GM; Sierra-Madero JG
    Vaccine; 2009 Nov; 27(50):7059-64. PubMed ID: 19799846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
    Kim DS; Jang GC; Cha SH; Choi SH; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Bang J; Naimi Z; Bouckenooghe A; Bosch-Castells V; Houillon G
    Pediatr Infect Dis J; 2016 Feb; 35(2):e60-4. PubMed ID: 26535878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.